Animal Models and Retroviral Vaccines Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, MD 20892, USA.
Viruses. 2011 Jun;3(6):861-85. doi: 10.3390/v3060861. Epub 2011 Jun 17.
The 3' end of the human T-cell leukemia/lymphoma virus type-1 (HTLV-1) genome contains four overlapping open reading frames (ORF) that encode regulatory proteins. Here, we review current knowledge of HTLV-1 orf-I and orf-II protein products. Singly spliced mRNA from orf-I encodes p12, which can be proteolytically cleaved to generate p8, while differential splicing of mRNA from orf-II results in production of p13 and p30. These proteins have been demonstrated to modulate transcription, apoptosis, host cell activation and proliferation, virus infectivity and transmission, and host immune responses. Though these proteins are not essential for virus replication in vitro, p8, p12, p13, and p30 have an important role in the establishment and maintenance of HTLV-1 infection in vivo.
人类 T 细胞白血病/淋巴瘤病毒 1 型(HTLV-1)基因组的 3' 端包含四个重叠的开放阅读框(ORF),编码调节蛋白。在这里,我们回顾了 HTLV-1 orf-I 和 orf-II 蛋白产物的现有知识。来自 orf-I 的单剪接 mRNA 编码 p12,可以被蛋白水解切割生成 p8,而来自 orf-II 的 mRNA 的差异剪接导致产生 p13 和 p30。这些蛋白已被证明可调节转录、凋亡、宿主细胞激活和增殖、病毒感染性和传播以及宿主免疫反应。尽管这些蛋白对于体外病毒复制不是必需的,但 p8、p12、p13 和 p30 在 HTLV-1 体内感染的建立和维持中起着重要作用。